Xtx Topco LTD Puma Biotechnology, Inc. Transaction History
Xtx Topco LTD
- $2.23 Billion
- Q2 2025
A detailed history of Xtx Topco LTD transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 104,424 shares of PBYI stock, worth $531,518. This represents 0.02% of its overall portfolio holdings.
Number of Shares
104,424
Previous 125,317
16.67%
Holding current value
$531,518
Previous $370,000
3.24%
% of portfolio
0.02%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding PBYI
# of Institutions
126Shares Held
33.4MCall Options Held
68.2KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.13MShares$21 Million9.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.71MShares$18.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$18.2 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.01MShares$10.2 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.87MShares$9.54 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $232M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...